REGENERON PHARMACEUTICALS, INC.
REGENERON PHARMACEUTICALS, INC.
TARRYTOWN, NY
Loading...
Price History
Market Data
| Market Cap | -351.81M |
| P/E Ratio | - |
| P/B Ratio | -0.01 |
| EPS | - |
| Dividend Yield | - |
| D/E Ratio | 0.30 |
| Current Ratio | 4.13 |
| Currency | USD |
Key Financial Metrics
14.34B
Revenue
4.50B
Net Income
-
EPS (Diluted)
6.64B
Free Cash Flow
Profitability
Gross Margin
85.4%
Operating Margin
24.9%
Net Profit Margin
31.4%
EBITDA
4.51B
Returns & Efficiency
Return on Assets (ROA)
11.1%
Return on Equity (ROE)
14.4%
Dividend Yield
-
EPS
-
Financial Health
Total Assets
40.56B
Total Debt
1.99B
Debt to Equity
0.30x
Current Ratio
4.13
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Chemicals & Allied Products |
| HQ | TARRYTOWN, NY |
| Fiscal Year | 2025 |
Peers
LILLY ELI & CO
LLY
931.26B
P/E: --
ELI LILLY & CO
LLY
931.26B
P/E: --
543.83B
P/E: --
ABBVIE INC.
ABBV
365.53B
P/E: --
BEIGENE, LTD.
BEIGF
306.50B
P/E: 632.4
BEONE MEDICINES LTD.
BEIGF
306.50B
P/E: 632.4
281.00B
P/E: --
MERCK & CO. INC.
MRK
281.00B
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap$-351.81M
P/E Ratio (TTM)-
Price to Book-0.01
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin85.4%
Operating Margin24.9%
Net Margin31.4%
ROE14.4%
ROA11.1%
Leverage & Liquidity
Debt to Equity0.30
Current Ratio4.13
Total Debt$1.99B
Total Assets$40.56B
Stockholders' Equity$31.26B
Income Statement (FY 2025)
Revenue$14.34B
Gross Profit$12.24B
Operating Income$3.58B
Net Income$4.50B
EPS (Diluted)-
Cash Flow (FY 2025)
Free Cash Flow$6.64B
Cash & Equivalents$3.12B
Revenue Growth1.0%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 777 OLD SAW MILL RIVER ROAD TARRYTOWN, NY 10591 |
| Phone | N/A |
| Incorporated | NY, US |
| EIN | 133444607 |
| Fiscal Year End | 1231 |
| Shares Outstanding | -500,000.00 |
| Stockholders' Equity | $31.26B |
| Cash & Equivalents | $3.12B |
Recent Filings
View All
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-05-04
Local
SCHEDULE 13G
Passive Ownership Report
Schedule 13G - passive beneficial ownership
Filed: 2026-04-30
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2026-04-29
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-04-29
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-04-08
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-03
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-23
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-11
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-11
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-02-09
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-02-09
Local
13F-HR
13F-HR Filing
SEC regulatory filing
Filed: 2026-02-06
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2026-02-04
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-10-28
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-08-01
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | REGENERON PHARMACEUTICALS, INC. |
| Ticker | REGN |
| Exchange | -- |
| Sector | Manufacturing |
| Industry | Chemicals & Allied Products |
| Headquarters | TARRYTOWN, NY |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | -351.81M |
| Revenue | 14.34B |
| Net Income | 4.50B |
| P/E Ratio | - |
| EPS | - |
| Net Margin | 31.4% |
| ROE | 14.4% |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...